Sonya Collins
The article discusses a clinical trial by U.S. researchers investigating the use of embryonic stem cells to halt the progression of age-related macular degeneration (AMD).
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: